IC
DXCM icon

Inscription Capital’s DexCom DXCM Stock Holding History

Inscription Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Sell
5,553
-1,347
-20% -$89.7K 0.03% 481
2026
Q1 		$433K Buy
6,900
+312
+5% +$21.7K 0.05% 396
2025
Q4 		$437K Buy
6,588
+3,030
+85% +$196K 0.04% 399
2025
Q3 		$239K Buy
+3,558
New +$282K 0.03% 529
2025
Q2 		– Sell
-2,000
Closed -$277K – 506
2025
Q1 		$277K Buy
+2,000
New +$163K 0.05% 260
2024
Q3 		– Sell
-2,015
Closed -$228K – 371
2024
Q2 		$228K Buy
2,015
+15
+0.8% +$1.9K 0.04% 306
2024
Q1 		$277K Hold
2,000
– – 0.05% 260
2023
Q4 		$248K Buy
+2,000
New +$204K 0.07% 183

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Inscription Capital's DXCM Position: Q2 2026 in Review

Inscription Capital reduced its DexCom (DXCM) stake by 20% in Q2 2026, selling an estimated $89.7K and leaving 5,553 shares worth $374K. The position accounts for 0.03% of the portfolio, ranked #481.

Inscription Capital first reported a position in DXCM in Q4 2023 and has held it in 8 quarters since. The position peaked at $437K in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Inscription Capital held 5,553 shares of DexCom worth $374K as of Q2 2026.
  • Inscription Capital sold 1,347 DexCom shares in Q2 2026, an estimated $89.7K.
  • DexCom made up 0.03% of Inscription Capital's portfolio in Q2 2026, its #481 holding.
  • Inscription Capital first reported a position in DexCom in Q4 2023 and has held it in 8 quarters since.
  • Inscription Capital's DexCom position peaked at $437K in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.